SUBSCRIBE
SUBSCRIBE

EvoGenix Limited Touts Positive Bone Treatment Results

January 16, 2006 | 
1 min read

EvoGenix (ASX:EGX) has reported results on the development of its product OVP, for the treatment of bone loss.

Australia
MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
Drug Development
Kazia’s Star Asset Suffers Surprise Letdown in Global Glioblastoma Study
August 2, 2022
 · 
3 min read
 · 
Tristan Manalac
Drug Development
Sapience, Intensity, Kazia and Transcenta Tout Early Success at ASCO
June 3, 2022
 · 
3 min read
 · 
Vanessa Doctor, RN
Drug Development
Inaugural Patient Injected with Cancer-Killing Oncolytic Virus
May 24, 2022
 · 
2 min read
 · 
Jazmine Colatriano M.S.